Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review

Basit Öğe Kaydı
dc.authorid0000-0002-6308-1763
dc.contributor.authorYamada, Yasuhiro
dc.contributor.authorUkimura, Osamu
dc.contributor.authorKaneko, Masatomo
dc.contributor.authorMatsugasumi, Toru
dc.contributor.authorFujihara, Atsuko
dc.contributor.authorVourganti, Srinivas
dc.contributor.authorMarks, Leonard
dc.contributor.authorSidana, Abhinav
dc.contributor.authorKlotz, Laurence
dc.contributor.authorSalomon, Georg
dc.contributor.authorde la Rosette, Jean J. M. C. H.
dc.date.accessioned2021-04-07T08:19:59Z
dc.date.available2021-04-07T08:19:59Z
dc.date.issued2021
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractObjective To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a replacement from SB in men at clinical risk of prostate cancer. Methods The non-systematic literature was searched for peer-reviewed English-language articles using PubMed, including the prospective paired studies, where the index test was MRI-TB and the comparator text was SB. Also the randomized clinical trials (RCTs) are included if one arm was MRI-TB and another arm was SB. Results Eighteen prospective studies used both MRI-TB and TRUS-SB, and eight RCT received one of the tests for prostate cancer detection. In most prospective trials to compare MRI-TB vs. SB, there was no significant difference in any cancer detection rate; however, MRI-TB detected more men with CSCa and fewer men with CISCa than SB. Conclusion MRI-TB is superior to SB in detection of CSCa. Since some significant cancer was detected by SB only, a combination of SB with the TB technique would avoid the underdiagnosis of CSCa.
dc.identifier.citationYamada, Y., Ukimura, O., Kaneko, M., Matsugasumi, T., Fujihara, A., Vourganti, S. ... de la Rosette, J. J. M. C. H. (2021). Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. World Journal of Urology, 39(3), 677-686. https://dx.doi.org/10.1007/s00345-020-03366-x
dc.identifier.doi10.1007/s00345-020-03366-x
dc.identifier.endpage686
dc.identifier.issn0724-4983
dc.identifier.issn1433-8726
dc.identifier.issue3
dc.identifier.scopusqualityQ1
dc.identifier.startpage677
dc.identifier.urihttps://dx.doi.org/10.1007/s00345-020-03366-x
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6709
dc.identifier.volume39
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofWorld Journal of Urologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectProstate Cancer
dc.subjectMagnetic Resonance Imaging
dc.subjectTarget Biopsy
dc.subjectSystematic Biopsy
dc.titleMoving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
delaRosette-Jean-2021.pdf
Boyut:
956.45 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu